Indefinite Delivery Contract SPE2DR25D9322

The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the United States Coast Guard, and the US Naval Fleet.

The contract, valued at $499,999,999, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The contract has a 30-month base period and three 30-month option periods, enabling the DLA to issue firm fixed-price delivery orders to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy, which aims to establish multiple regional contracts to ensure the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters.